Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-185

Yes, agree with you @BCHD. @PARdonthepun, I’ve been watching NEU closely, not an investor, but I think you are as remember seeing your posts in the forum. Looking at the graph you posted confirmed something I had been thinking for a while and that is I think it better to sit on the sidelines until P3 in biotech. While you can make big bucks getting in early, the risk is massive and you just set yourself up for capital raise after capital raise and a lot of promises that don’t materialise. Anyway, I’m staying in this one as I know this drug works but would really like to see some rubber hit the road such as an MPS deal.